Evidence map›Paper›PMID 39989267›Full record

ArticleBiotechnology journal2025

Enzymatically Crafted Bacterial Cellulose Nanoparticles Functionalized With Antimicrobial Peptides: Toward Sustainable Antimicrobial Formulations.

Martina Schibeci, Rosa Gaglione, Noemi Russo, Raffaele Velotta, Bartolomeo Della Ventura, Angela Arciello

Abstract read
In one paragraph

Article in Biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Martina SchibeciDepartment of Chemical Sciences, University of Naples Federico II, Naples, Italy.
Rosa GaglioneDepartment of Chemical Sciences, University of Naples Federico II, Naples, Italy.
Noemi RussoDepartment of Chemical Sciences, University of Naples Federico II, Naples, Italy.ORCID https://orcid.org/0009-0007-1239-2602
Raffaele VelottaDepartment of Physics "Ettore Pancini", University of Naples Federico II, Naples, Italy.ORCID https://orcid.org/0000-0003-1077-8353
Bartolomeo Della VenturaDepartment of Physics "Ettore Pancini", University of Naples Federico II, Naples, Italy.
Angela ArcielloDepartment of Chemical Sciences, University of Naples Federico II, Naples, Italy.ORCID https://orcid.org/0000-0001-8269-6459

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although natural antimicrobial peptides (AMPs) are endowed with excellent antimicrobial properties, only a few of them have been successfully translated to the market so far. This is mainly due to their short half-life, to their high susceptibility to protease degradation, and to the lack of appropriate strategies for their efficient targeted delivery. Hence, the development of an effective system to deliver AMPs to the site of infection is urgent. The system here selected is represented by bacterial cellulose nanoparticles (BCNPs). Nanocellulose has recently emerged as one of the most promising "green" materials, attracting great attention due to its unique features, including biodegradability, sustainability, biocompatibility, and special physicochemical properties. To produce BCNPs, Komagataeibacter xylinus has been selected as host producing strain. Once obtained BC macrofibers, the production of BCNPs was set up by enzymatic hydrolysis using a commercial mixture of cellulases from Trichoderma reesei to develop a sustainable green biotechnological process. The storage stability of produced BCNPs has been also evaluated. Obtained BCNPs have been functionalized through non-covalent bindings with an antimicrobial peptide previously identified in human apolipoprotein B and found to be endowed with strong antimicrobial properties in in vitro analyses and with good biocompatibility profiles when analyzed on human skin cells. This opens interesting perspectives to the applicability of the developed system in several biotechnological fields.

Indexed as

Anti-Infective AgentsAntimicrobial PeptidesCelluloseNanoparticlesAcetobacteraceaeGluconacetobacter xylinusGreen Chemistry TechnologyHumansAnti-Infective AgentsAntimicrobial PeptidesCelluloseantimicrobial formulationsbacterial cellulose nanoparticlescellulose enzymatic hydrolysishost defence peptidesKomagataeibacter xylinussustainable production processes

Identifiers

PMID39989267
PMCPMC11848709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.